ArticleAtherosclerosis2010

Non-nucleoside reverse transcriptase inhibitor efavirenz increases monolayer permeability of human coronary artery endothelial cells.

Md Saha Jamaluddin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.